Marcus Vinicius Guimarães de Lacerda

Adjunct Professor

University of Texas Medical Branch

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marcus Vinicius Guimarães de Lacerda is an Adjunct Professor at the University of Texas Medical Branch, USA. His research areas include malaria elimination, pharmacovigilance, cryptococcosis, and the impacts of COVID-19 vaccination. He has contributed to various studies, such as assessing risk factors for malaria-related deaths in Brazil and evaluating the efficacy of dual therapy in treatment-naive individuals.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Fabien Zoulim

Université Claude Bernard Lyon 1

FRANCE

Marcus Vinicius Guimarães de Lacerda

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Towards Malaria Elimination: A Nationwide Case–Control Study to Assess Risk Factors for Severe Malaria‐Related Deaths in Brazil

An observational pilot study of an active surveillance tool to enhance pharmacovigilance in Brazil

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts &lt;200/mm3: 48-Week Results of the DOLCE Study

Cutaneous cryptococcosis resembling keratoacanthoma

Fluconazole Resistance and Heteroresistance in Cryptococcus spp.: Mechanisms and Implications

Factors influencing adverse events following COVID-19 vaccination

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'

Impact of Respiratory Support During Hospitalization on Functional Outcomes in Long COVID: A Post-Hoc Analysis of a Prospective Cohort Study

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis

Ocular manifestations in patients diagnosed with dengue in a reference hospital in the city of Manaus, Brazil

Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis

Snakebite envenomations and access to treatment in communities of two indigenous areas of the Western Brazilian Amazon: A cross-sectional study

Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination

Evolution and assembly of Anopheles aquasalis 's immune genes: primary malaria vector of coastal Central and South America and the Caribbean Islands

Repercussions and Legacy of the COVID-19 Pandemic in Manaus, Brazil: The Health Managers’ Perspective

Detection of Zika Virus in Aedes aegypti and Aedes albopictus Mosquitoes Collected in Urban Forest Fragments in the Brazilian Amazon

Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil

Frequency of pleural effusion in dengue patients by severity, age and imaging modality: a systematic review and meta-analysis

Collaborators (18)

Fabien Zoulim

John Campbell

Clinton Colaco

James A Watson

Mauricio Nogueira

Francois Nosten

David Lynn

Jesús Rodríguez-Baño

Richard Price

Tor Biering-Sørensen

Nigel Curtis

Natalie Stevens

Felix Jackson

Joel Tarning

Michaela Buenemann

Nikos Vasilakis

Javier Crespo

Chris Drakeley

Make your next move.

Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study